InvestorsHub Logo
Followers 134
Posts 3738
Boards Moderated 0
Alias Born 01/28/2006

Re: MaskedCat post# 369250

Friday, 08/06/2021 8:24:14 PM

Friday, August 06, 2021 8:24:14 PM

Post# of 402925
Remdesivir was given an EUA at the interim report of its Phase 3 study. That's my best guess for Brilacin.

It could be sooner if the Phase 2 shows outstanding results, acing all the primary and secondary outcomes with absolute safety.

The other factor is the status of the pandemic. If the Delta virus outbreak continues to accelerate or if vaccine resistant or more deadly variants appear, Brilacidin could be pushed up to the drug of choice.

JMHO Farrell
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News